Opus Genetics (IRD) Depreciation and Depletion (2011 - 2026)
Opus Genetics' (IRD) quarterly Depreciation and Depletion came in at $13000.0 in Q1 2026, little changed year-on-year from $13000.0 in Q1 2025, and little changed on a QoQ basis from $13000.0 in Q4 2025.
Opus Genetics (IRD) Depreciation and Depletion (2011 - 2026) Analysis & Trends
Opus Genetics (IRD) has 12 years of Depreciation and Depletion data on file, last reported at $13000.0 in Q1 2026.
- On a quarterly basis, Depreciation and Depletion changed 0.0% year-over-year to $13000.0 in Q1 2026; TTM through Mar 2026 was $53000.0, a 130.43% increase from a year earlier, with the FY2025 full-year figure at $53000.0, up 430.0% from the prior year.
- Depreciation and Depletion for Q1 2026 stood at $13000.0, roughly flat from $13000.0 in the prior quarter.
- Over the last five years, Depreciation and Depletion for IRD reached as high as $14000.0 in Q2 2025 and fell as low as $1000.0 in Q1 2022.
- Historically, Depreciation and Depletion has averaged $6142.9 across 5 years, with a median of $2000.0 in 2022.
- Across the five-year window, Depreciation and Depletion changed 0.0% in 2022 and soared 233.33% in 2024, its largest moves.
- Year by year, Depreciation and Depletion stood at $1000.0 in 2022, then jumped by 200.0% to $3000.0 in 2023, then surged by 233.33% to $10000.0 in 2024, then gained by 30.0% to $13000.0 in 2025, then changed by 0.0% to $13000.0 in 2026.
- Per Business Quant data, the three most recent Depreciation and Depletion figures were $13000.0 in Q1 2026, $13000.0 in Q4 2025, and $13000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 196,658.72 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 39.39 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 2.20 Mn |
| 10 | Opus Genetics | 263.72 Mn | 203.72 Mn | - | 13,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 13,000.00 |
| Mar 31, 2026 | 13,000.00 |
| Dec 31, 2025 | 13,000.00 |
| Dec 31, 2025 | 13,000.00 |
| Sep 30, 2025 | 13,000.00 |
| Sep 30, 2025 | 13,000.00 |
| Jun 30, 2025 | 14,000.00 |
| Jun 30, 2025 | 14,000.00 |
| Mar 31, 2025 | 13,000.00 |
| Mar 31, 2025 | 13,000.00 |
| Dec 31, 2024 | 10,000.00 |
| Dec 31, 2024 | 10,000.00 |
| Dec 31, 2023 | 3,000.00 |
| Dec 31, 2023 | 3,000.00 |
| Sep 30, 2023 | 1,000.00 |
| Sep 30, 2023 | 1,000.00 |
| Jun 30, 2023 | 1,000.00 |
| Jun 30, 2023 | 1,000.00 |
| Mar 31, 2023 | 1,000.00 |
| Mar 31, 2023 | 1,000.00 |